TREATING OCD

Cards (19)

  • WHAT APPROACH IS USED TO TREAT OCD?
    biological
  • WHAT DOES THE BIOLOGICAL APPROACH SUGGEST?
    OCD has a physical cause
  • WHY IS DRUG THERAPY AN APPROPRIATE WAY TO TREAT OCD?
    creates physical changes to neural mechanisms
  • WHAT IS THE MAIN TYPE OF DRUG USED TO TREAT OCD?
    SSRIs
  • WHAT DOES SSRI STAND FOR?
    selective serotonin reuptake inhibitors
  • ONE TYPE OF SSRI?
    fluoxetine
  • WHAT IS A TYPICAL DAILY DOSAGE OF FLUOXETINE?
    20 mg
  • WHAT IS THE MAXIMUM DOSAGE OF FLUOXETINE?
    60 mg
  • HOW DO SSRIS INCREASE SEROTONIN LEVELS IN PATIENTS?
    • inhibit reabsorption of serotonin in pre-synaptic neuron
    • increases serotonin in synapse
    • has an effect on post-synaptic neuron
    • reduces anxiety (emotional characteristics of OCD)
    • reduces need to display compulsive behaviour
  • ANOTHER FORM OF DRUG USED TO TREAT OCD?
    tricyclics
  • WHAT DO TRICYCLICS DO?
    block reabsorption of serotonin and noradrenaline
  • WHY ARE SOME PATIENTS REQUIRED TO HAVE TRICYCLICS AND NOT SSRIs?
    some patients don't respond to SSRIs
  • WHAT IS THE ISSUE WITH TRICYCLICS COMAPRED TO SSRIs?
    more severe side effects
  • STRENGTHS OF DRUG THERAPY?
    • real world application
    • has research support
    • practical
  • WEAKNESSES OF DRUG THERAPY?
    • side effects
    • not universal
  • WHY IS DRUG THERAPY NOT UNIVERSAL?
    • side effects (sexual dysfunction, blurred vision, weight gain, fatigue)
    • people react differently (withdrawal/ no effect/) = low consistency
    • not appropriate for all
  • WHY DOES DRUG THERAPY HAVE REAL WORLD APPLICATION?
    • effects experienced quicker (quicker treatment)
    • integrate better into society
    • boost economy
  • WHAT RESEARCH SUPPORT DOES DRUG THERAPY HAVE?
    • Soomro et al
    • SSRIs significantly better than placebos (17 clinical trials)
    • at reducing OCD symptoms
    • effective form of treatment
  • WHY IS DRUG THERAPY PRACTICAL?
    • cost effective (cheaper than therapy for NHS and patient)
    • more beneficial to economy
    • non-disruptive (requires less commitment than therapy)
    • more likely to maintain symptom reduction